Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
p53 is a critical tumor suppressor protein that regulates cell division by preventing cells from proliferating too rapidly or in an uncontrolled manner. It acts as a transcription factor, binding directly to DNA in the nucleus of cells throughout the body. When cellular DNA is damaged by factors such as chemicals, radiation, or UV light, p53 determines whether the damage can be repaired. If repair is possible, it activates genes involved in DNA repair; if not, it signals for apoptosis (programmed cell death), thereby preventing propagation of potentially cancerous cells. TP53 is mutated in over half (>50%) of all human cancers.
Induces expression of genes involved in cell cycle arrest, apoptosis, senescence, and DNA repair.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor suppressor protein p53 (p53).